Thursday, 13 Dec 2018

PsA/SpA

Datesort ascending Type Title Save
14 Jun 2018 Social RT @AlexSepriano: What #IL17i can do in patients with #AxialSpA. HOT session #EULAR2018 @sofiaramiro82 @EMEUNET https://t.co/5bNpKPyK0H
14 Jun 2018 ACR Video Dr. Olga Petryna EULAR 2018 - Serum Calprotectin in Behcet's and PsA Posters
14 Jun 2018 News Cardiovascular Risk Factors in Psoriasis, PsA and Seronegative SpA
13 Jun 2018 Social RT @DrPetryna: #EULAR18 @RheumNow ABST op0067 Increased Dickkopf-1 (DKK1)( a natural inhibitor of Wnt signalling pathway) associated with d…
13 Jun 2018 Social Lindstrom studied their Swedish AS registry and found that While the presence of Uveitis was assoc w/ better TNFi responses; all other comorbidities yielded lesser TNFi responses. #EULAR2018 @RheumNow OP0023 https://t.co/bltRC4khbL
13 Jun 2018 Social RT @DrPetryna: #EULAR18 @RheumNow ABST op0028 BCD-085, novel humanised monoclonal IL-17 Ab w/ genetically modified Fc- and CDR-regions sho…
02 Jun 2018 Social RheumNow Wk in Review is up. Good news for GPA and Renal transplant, Early RA challenges, Vaccinots and HPV and the risk of cancer in PsA. Check out the podcast https://t.co/nqif5yPBx9 or the website video https://t.co/bj6ar7ZlYT
31 May 2018 News MRI Imaging for Sacroiliitis Requires Bone Marrow Edema for Reliability
29 May 2018 Social UCB announces the FDA has approved Cimzia (certolizumab) for use in moderate to severe plaque psoriasis based on over 1000 pts in Phase 3 RCTs CIMPASI-1, CIMPASI-2 and CIMPACT and PASI75 of 75-82% at wk16 https://t.co/PYx15htd3Z
29 May 2018 Social Certolizumab is now FDA approved for use in Crohns disease, Rheumatoid arthritis, Ankylosing spondylitis, psoriatic arthritis and now Psoriasis.https://t.co/QVpmv7V9PI
29 May 2018 News Cancer Risk Raised in Psoriatic Arthritis
17 May 2018 News Trends in Psoriatic Arthritis Treatment 2004-2015
14 May 2018 News Ankylosing Spondylitis Women Show Less Durable Responses to TNF Inhibitors
14 May 2018 Slide of the day Rare Risk of Colitis with IL-17 Inhibitors
13 May 2018 Social RT @NatRevRheumatol: Our new #Review is online! Gladman and colleagues highlight the similarities and differences between #AnkylosingSpondy…
03 May 2018 News Targeting IL-17A: A Winner in PsA
01 May 2018 News Comorbidities Undermine Clinical Outcomes in Psoriatic Arthritis
30 Apr 2018 Social April meeting of European Medicines Agency, the Committee for Medicinal Products for Human Use (CHMP) recommended the approval of new indications for CIMZIA- certolizumab pegol (for plaque psoriasis) and XELJANZ-tofacitinib (for psoriatic arthritis). https://t.co/W4A0AIyZ80
19 Apr 2018 Social RT @LCalabreseDO: Anxiously await PHASE 3 Tocilizumab PSS study. The extension is provocative. Toxicity will be key based on effect size ht…
10 Apr 2018 News Apremilast in DMARD-Naive Psoriatic Arthritis